Cargando…
MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy
Background: T-type Ca(2+) channels (Ca(v)3) represent emerging therapeutic targets for a range of neurological disorders, including epilepsy and pain. To aid the development and optimisation of new therapeutics, there is a need to identify novel chemical entities which act at these ion channels. A n...
Autores principales: | Harman, Thomas, Udoh, Michael, McElroy, Dan L., Anderson, Lyndsey L., Kevin, Richard C., Banister, Samuel D., Ametovski, Adam, Markham, Jack, Bladen, Chris, Doohan, Peter T., Greba, Quentin, Laprairie, Robert B., Snutch, Terrance P., McGregor, Iain S., Howland, John G., Arnold, Jonathon C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110893/ https://www.ncbi.nlm.nih.gov/pubmed/37082241 http://dx.doi.org/10.3389/fphys.2023.1086243 |
Ejemplares similares
-
The type 1 cannabinoid receptor positive allosteric modulators GAT591 and GAT593 reduce spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg
por: McElroy, Dan L., et al.
Publicado: (2022) -
Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents
por: Hur, Kwang-Hyun, et al.
Publicado: (2022) -
Olivetolic acid, a cannabinoid precursor in Cannabis sativa, but not CBGA methyl ester exhibits a modest anticonvulsant effect in a mouse model of Dravet syndrome
por: Anderson, Lyndsey L., et al.
Publicado: (2022) -
Characterization of cannabinoid plasma concentration, maternal health, and cytokine levels in a rat model of prenatal Cannabis smoke exposure
por: Black, Tallan, et al.
Publicado: (2023) -
Fast oxygen dynamics as a potential biomarker for epilepsy
por: Farrell, Jordan S., et al.
Publicado: (2018)